Published Oct 9, 2026, 7:15 AM ET · Updated a month ago · 1 source

Fidelity-Backed City Therapeutics Seeks $184.7 Million in US IPO

bloomberg

Original Report

City Therapeutics Inc., an early-stage developer of RNAi-based drugs, is seeking to raise as much as $184.7 million in a US initial public offering.